COMP <GO>
EXEL vs BNTX // ENTERPRISE SCALE & MARKET CAP
Exelixis Inc. (NASDAQ) VS. BioNTech SE (NASDAQ) • 15-METRIC TALLY: EXEL 9
— BNTX 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BNTX
LAST: $69.39 (+4.82%) • MKT CAP: $16.40B
market-cap
$16.40B
LAST: $88.17 (-1.08%) • MKT CAP: $22.39B
market-cap
$22.39B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EXEL VS. BNTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EXEL | BNTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.10% | 9.90% | +25.20 | EXEL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.4x | 21.0x | -2.60 | EXEL | /valuation <GO> |
| Free Cash Flow Yield | 5.34% | 2.21% | +3.13 | EXEL | /fcf-yield <GO> |
| Operating Margin | 37.60% | 13.90% | +23.70 | EXEL | /operating-margins <GO> |
| Net Profit Margin | 33.70% | 10.90% | +22.80 | EXEL | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | 14.30% | -7.30 | BNTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 16.64 | 3.74 | +12.90 | EXEL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | EXEL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.3 | 43.4 | +19.90 | EXEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 1.02 | -0.06 | BNTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.5x | 27.6x | -8.10 | EXEL | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $16.40B | $22.39B | -$5.99B | BNTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EXEL REV | BNTX REV | EXEL GROSS % | BNTX GROSS % | EXEL FCF | BNTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.32B | — | 96.4% | — | $875.8M | — |
| FY 2024 | $2.17B | — | 96.5% | — | $671.5M | — |
| FY 2023 | $1.83B | — | — | — | $251.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EXEL // BETA 0.96
BNTX // BETA 1.02